These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19883213)

  • 21. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
    Li X; Ding L; Xu Y; Wang Y; Ping Q
    Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and development of liposomes incorporating a bioactive labdane-type diterpene. In vitro growth inhibiting and cytotoxic activity against human cancer cell lines.
    Matsingou C; Dimas K; Demetzos C
    Biomed Pharmacother; 2006 May; 60(4):191-9. PubMed ID: 16675195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tatp-mediated intracellular delivery of pharmaceutical nanocarriers.
    Torchilin VP
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):816-20. PubMed ID: 17635155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New cytotoxic rosamine derivatives selectively accumulate in the mitochondria of cancer cells.
    Lim SH; Wu L; Burgess K; Lee HB
    Anticancer Drugs; 2009 Jul; 20(6):461-8. PubMed ID: 19387338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies.
    Poste G
    Cancer Treat Rep; 1986 Jan; 70(1):183-99. PubMed ID: 3510734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoliposomes for cancer therapy.
    Kontermann RE
    Curr Opin Mol Ther; 2006 Feb; 8(1):39-45. PubMed ID: 16506524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liposomes-mediated delivery of pro-apoptotic therapeutic membrane proteins.
    Liguori L; Marques B; Villegas-Mendez A; Rothe R; Lenormand JL
    J Control Release; 2008 Mar; 126(3):217-27. PubMed ID: 18234390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Micro- and nanocarrier-mediated lung targeting.
    Kurmi BD; Kayat J; Gajbhiye V; Tekade RK; Jain NK
    Expert Opin Drug Deliv; 2010 Jul; 7(7):781-94. PubMed ID: 20560777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluorescence microscopy to follow the targeting of liposomes and micelles to cells and their intracellular fate.
    Torchilin VP
    Adv Drug Deliv Rev; 2005 Jan; 57(1):95-109. PubMed ID: 15518923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liposomes as drug delivery system: a strategic approach for the treatment of HIV infection.
    Désormeaux A; Bergeron MG
    J Drug Target; 1998; 6(1):1-15. PubMed ID: 9769017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases.
    Yamada Y; Harashima H
    Adv Drug Deliv Rev; 2008; 60(13-14):1439-62. PubMed ID: 18655816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Niosomes in sustained and targeted drug delivery: some recent advances.
    Azeem A; Anwer MK; Talegaonkar S
    J Drug Target; 2009 Nov; 17(9):671-89. PubMed ID: 19845484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy.
    Zhang E; Zhang C; Su Y; Cheng T; Shi C
    Drug Discov Today; 2011 Feb; 16(3-4):140-6. PubMed ID: 21182981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liposomes a vesicular nanocarrier: potential advancements in cancer chemotherapy.
    Kumar P; Gulbake A; Jain SK
    Crit Rev Ther Drug Carrier Syst; 2012; 29(5):355-419. PubMed ID: 22876808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular vehicles for mitochondrial chemical biology and drug delivery.
    Rin Jean S; Tulumello DV; Wisnovsky SP; Lei EK; Pereira MP; Kelley SO
    ACS Chem Biol; 2014 Feb; 9(2):323-33. PubMed ID: 24410267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent approaches to intracellular delivery of drugs and DNA and organelle targeting.
    Torchilin VP
    Annu Rev Biomed Eng; 2006; 8():343-75. PubMed ID: 16834560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biocompatible magnetic liposomes for temperature triggered drug delivery.
    Ding X; Cai K; Luo Z; Li J; Hu Y; Shen X
    Nanoscale; 2012 Oct; 4(20):6289-92. PubMed ID: 22976154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DQAsomes as the prototype of mitochondria-targeted pharmaceutical nanocarriers: preparation, characterization, and use.
    Weissig V
    Methods Mol Biol; 2015; 1265():1-11. PubMed ID: 25634263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting drugs to mitochondria.
    Heller A; Brockhoff G; Goepferich A
    Eur J Pharm Biopharm; 2012 Sep; 82(1):1-18. PubMed ID: 22687572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticancer efficacy and subcellular site of action investigated by real-time monitoring of cellular responses to localized drug delivery in single cells.
    Zheng XT; Chen P; Li CM
    Small; 2012 Sep; 8(17):2670-4. PubMed ID: 22736525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.